Csl Behring Ag drugs

3 results

  • hizentra

    (Human Immunoglobulin G)
    Csl Behring Ag
    Hizentra is indicated as replacement therapy for primary humoral immunodeficiency (PI) in adults and pediatric patients aged 2 and older, and as maintenance therapy to prevent relapse of neuromuscular disability and impairment in adults with chronic inflammatory demyelinating polyneuropathy (CIDP).
    Medication Details
    Drug Interactions

  • privigen

    (Human Immunoglobulin G)
    Csl Behring Ag
    Privigen treats primary humoral immunodeficiency (including CVID, agammaglobulinemia, and Wiskott-Aldrich syndrome), chronic immune thrombocytopenic purpura (ITP) in patients 15+, and chronic inflammatory demyelinating polyneuropathy (CIDP) in adults.
    Medication Details
    Drug Interactions

  • rhophylac

    (Human Rho(D) Immune Globulin)
    Csl Behring Ag
    Rhophylac suppresses Rh isoimmunization in Rh(D)-negative patients during pregnancy, obstetric complications, or after incompatible transfusions with Rh(D)-positive blood. Also indicated to raise platelet counts in Rh(D)-positive, non-splenectomized adults with chronic immune thrombocytopenic purpura (ITP).
    Medication Details
    Drug Interactions